Genetic discovery reveals who can benefit from preterm birth therapy

A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.

Leave A Comment

Your email address will not be published. Required fields are marked *